Numbers of prenatal cell-free DNA screens performed: Results of a 2022 CAP exercise.

Glenn E PalomakiPhilip WyattRoss RowseyPhillip Michael CacherisNathalie LepageMarvin R NatowiczThomas LongAnn M Moyer

Published in: Prenatal diagnosis (2024)

In 2011, screening for common trisomies was based on serum/ultrasound markers with an estimated 2.96 million US pregnancies screened in 131 laboratories. In 2022, cfDNA-based screening was offered by 20 laboratories testing 2.18 million US pregnancies.

Keyphrases

preterm birth
gestational age
pregnant women
magnetic resonance imaging
pregnancy outcomes
high intensity
high throughput
physical activity
genome wide
computed tomography
ultrasound guided
body composition
single cell